- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SHUTTLE PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 14.11. | SHPH-Aktie erreicht 52-Wochen-Tief bei 1,02 US-Dollar | 1 | Investing.com Deutsch | ||
| 14.11. | SHPH stock touches 52-week low at $1.02 amid market challenges | 1 | Investing.com | ||
| 13.11. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Provides Third Quarter 2024 Corporate Update | 48 | GlobeNewswire (Europe) | GAITHERSBURG, Md., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical... ► Artikel lesen | |
| 13.11. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11. | Shuttle Pharmaceuticals Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 30.10. | Shuttle Pharmaceuticals dips 6%, prices $3.5M share offering | 3 | Seeking Alpha | ||
| 30.10. | Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules | 3 | GlobeNewswire (USA) | ||
| 29.10. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma | 92 | GlobeNewswire (Europe) | GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma"), a discovery and development stage specialty pharmaceutical company focused... ► Artikel lesen | |
| 29.10. | Pre-market Movers: GlycoMimetics, BIO-key International, Lixte Biotechnology, Shuttle Pharmaceuticals, Profire Energy | 387 | AFX News | NORWALK (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.30 A.M. ET).In the Green GlycoMimetics, Inc. (GLYC) is up over 163% at $0.4433.
BIO-key... ► Artikel lesen | |
| 29.10. | Shuttle Pharma Updates On Clinical Trial Site; Stock Surges | 6 | RTTNews | ||
| 28.10. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma | 28 | GlobeNewswire (Europe) | GAITHERSBURG, Md., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma"), a discovery and development stage specialty pharmaceutical company focused... ► Artikel lesen | |
| 25.10. | Shuttle Pharmaceuticals schließt Finanzierungsrunde ab und sammelt 790.000 US-Dollar ein | 1 | Investing.com Deutsch | ||
| 25.10. | Shuttle Pharmaceuticals completes funding round, raises $790,000 | 2 | Investing.com | ||
| 25.10. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.10. | Shuttle Pharmaceuticals Holdings, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 17.10. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.10. | SHPH stock touches 52-week low at $1.11 amid market challenges | 2 | Investing.com | ||
| 20.09. | Shuttle Pharmaceuticals files for offering common stock, warrants | 2 | Seeking Alpha | ||
| 20.09. | Shuttle Pharmaceuticals Holdings, Inc. - S-1, General form for registration of securities | 5 | SEC Filings | ||
| 16.09. | Shuttle Pharma erweitert klinische Studie zur Glioblastom-Behandlung | 1 | Investing.com Deutsch |
Seite:
1 2 3 Weiter >>
49 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRIA THERAPEUTICS | 9,050 | -0,55 % | Astria TherapeuticS GAAP EPS of -$0.42 in-line | ||
| ROCKET LAB USA | 19,020 | -0,63 % | Is Rocket Lab Stock a Millionaire Maker? | ||
| BOIRON | 29,700 | +1,37 % | BOIRON: EVOLUTION OF GOVERNANCE | July 3rd, 2024
The Board of Directors of Laboratoires BOIRON, meeting today under the chairmanship of Thierry BOIRON, has enacted an evolution of the Group's governance.
In this context, Thierry... ► Artikel lesen | |
| HARROW | 42,440 | 0,00 % | Pre-market Movers: California BanCorp, Harrow, Inc., Quantum Computing, BTC Digital, Calidi Biotherapeutics | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.15 A.M. ET).In the Green California BanCorp. (BCAL) is up over 33% at $23.01.
Quantum... ► Artikel lesen | |
| MEDICINOVA | 1,700 | 0,00 % | MediciNova, Inc.: MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders | LA JOLLA, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| ESSA PHARMA | 1,745 | 0,00 % | ESSA Pharma: NBC-Anlegerclub feiert schnelle +23% Rendite! | Der No Brainer Club (NBC) hat erneut sein Gespür für unterbewertete Biotech-Perlen unter Beweis gestellt. Mit ESSA Pharma konnten Mitglieder in diesem fulminanten Biotech-Herbst innerhalb weniger Tage... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,735 | 0,00 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update | Anaphylm (epinephrine) Sublingual Film pre-NDA meeting scheduled for fourth quarter 2024AQST-108 (epinephrine) Topical Gel pre-IND meeting scheduled for fourth quarter 2024Libervant® (diazepam) Buccal... ► Artikel lesen | |
| SHINECO | 2,510 | 0,00 % | SHINECO, INC. - 10-Q, Quarterly Report | ||
| LYRA THERAPEUTICS | 0,178 | 0,00 % | Lyra Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary | ||
| CUMBERLAND PHARMACEUTICALS | 1,120 | 0,00 % | Cumberland Pharma-Aktie erreicht 52-Wochen-Tief bei 1,07 US-Dollar | ||
| CYANOTECH | 0,260 | 0,00 % | Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2025 | KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation (OTCQB: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results... ► Artikel lesen | |
| REVIVA PHARMACEUTICALS | 1,220 | 0,00 % | Reviva Pharmaceuticals: Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights | - 108 patients have completed 1-year of treatment in 1-year open-label extension (OLE) trial - - Vocal biomarker speech latency data from RECOVER trial reinforce brilaroxazine's improvement on negative... ► Artikel lesen | |
| OMNIAB | 3,905 | 0,00 % | OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights | EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and nine months ended September 30, 2024, and provided operating and partner program... ► Artikel lesen | |
| BAYER | 19,260 | -1,45 % | Daimler-Truck, dynaCERT, Bayer AG: Gegensätze im 3. Quartal: Etablierte unter Druck, Newcomer mit Durchbruch | Etablierte DAX-Konzerne wie die Bayer AG und Daimler Truck, ein Unternehmen der Mercedes-Benz Gruppe, kämpfen im dritten Quartal 2024 mit Gegenwind. Doch der kanadische Cleantech-Spezialist dynaCERT... ► Artikel lesen | |
| MERCK KGAA | 138,20 | +0,07 % | Merck: Solide Zahlen | Merck KGaA lässt den Durchhänger nach dem Corona-Boom weiter hinter sich. Auch im vergangenen Quartal sorgte ein sich in Teilen erholendes Geschäft mit Halbleitermaterialien beim Dax-Konzern für Auftrieb... ► Artikel lesen |
Das Unternehmen SHUTTLE PHARMACEUTICALS HOLDINGS INC kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,890 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHUTTLE PHARMACEUTICALS HOLDINGS INC finden Sie auf Wallstreet Online.
